semaglutide pregnancy studies GLP-1 Medications and Pregnancy: When to Stop Before Conceiving Semaglutide exposure in early pregnancy

Wegovy was approved by the TGA in August 2024 as a treatment for chronic weight management but denied for the PBS

For type 2 diabetes management (as opposed to weight loss alone), semaglutide is also marketed as Ozempic at a maximum dose of 2.0 mg weekly

Moreover, alveolar lining fluid had GLP-1 concentrations that were substantially higher than those in serum [46]

This visual asset is designed to support: Pharmacy students (aligned with Pharm-D curriculum standards) Healthcare professionals for quick clinical revision Awareness on emerging anti-obesity pharmacotherapy Continuous learning and evidence-based application are essential as we move toward precision medicine in metabolic diseases